Designer drugs: mechanism of action and adverse effects
Abstract Electronic supplementary material: The online version of this article (10.1007/s00204-020-02693-7) contains supplementary material, which is available to authorized users.…
Abstract Electronic supplementary material: The online version of this article (10.1007/s00204-020-02693-7) contains supplementary material, which is available to authorized users.…
Abstract Medicinal use of Cannabis sativa L. has an extensive history and it was essential in the discovery of phytocannabinoids,…
Abstract Tetrahydrocannabinol (THC) is the primary psychoactive ingredient in cannabis. While the safety of THC and cannabis has been extrapolated…
Abstract Cannabis use in the management of musculoskeletal diseases has gained advocacy since several states have legalized its recreational use.…
Abstract The United States is swiftly moving toward increased legalization of medical and recreational cannabis. Currently considered the most commonly…
Abstract The endocannabinoid system (ECS) has received extensive attention for its neuroprotective effect on the brain. This system comprises endocannabinoids,…
Abstract Social isolation (SI) stress has been recognized as a major risk factor of morbidity in humans and animals, exerting…
Abstract Potential therapeutic actions of the cannabinoids delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are based on their activity as analgesics, anti-emetics,…
Abstract There are few medications with demonstrated efficacy for the treatment of posttraumatic stress disorder (PTSD). Treatment guidelines have unequivocally…
Abstract Medicine has utilised plant‐based treatments for millennia, but precisely how they work is unclear. One approach is to use…